MAM
magicpin names Pranay Gupta as VP, growth & business development
MUMBAI: Homegrown savings app magicpin has appointed Pranay Gupta as the new vice president of growth and business development. His appointment comes on the heels of other key strategic additions to the leadership team of magicpin.
Gupta will be responsible for building ecosystem partnerships for driving magicpin’s growth, the company said in a statement.
Gupta was the co-founder of 91 Springboard and is well-networked in the technology ecosystem. A graduate of IIM Ahmedabad and IIT-Delhi, he has decades of experience as an entrepreneur and investor.
On his new role, Pranay Gupta stated, “magicpin is a fantastic platform that lets consumers save, while driving growth for its 150K+ merchants. I am eager to join the team and build partnerships that take magicpin’s massive savings network to many more consumers.”
magicpin co-founder and CEO Anshoo Sharma said, “We are excited to welcome Pranay to the magicpin family. He brings a lot of experience, expertise, and valuable insights to the position, and we look forward to him playing a key role in the company’s next phase of growth.”
MAM
Beacon Group appoints Dr Rajesh Patel as Group CEO
36-year healthcare veteran to lead Beacon Diagnostics, Vector Biotek, Biogeny.
MUMBAI: A new chief, a fresh diagnosis and a sharper prescription for growth. Beacon Group has appointed Dr Rajesh Patel as its Group Chief Executive Officer, effective April 1, 2026, signalling a decisive push to scale its presence in the diagnostics and IVD space. Patel steps into the role with 36 years of experience across the healthcare and diagnostics industry, bringing a career shaped by leadership roles spanning sales, marketing, business development and operational strategy. His mandate is both expansive and precise: to steer the group’s overall strategic direction while tightening coordination across its three core entities Beacon Diagnostics, Vector Biotek and Biogeny Diagnostics.
In practical terms, that means driving cross-company synergies, accelerating market expansion and strengthening organisational capability areas increasingly critical as diagnostic players compete for scale in a fragmented yet rapidly evolving healthcare ecosystem. The group is positioning itself to capture unmet demand across chain laboratories, key accounts and standalone labs, segments that remain underserved despite growing diagnostic needs.
The appointment comes at a time when the In Vitro Diagnostics (IVD) sector in India is entering a more competitive and innovation-led phase, with companies focusing not just on product pipelines but also on service delivery, integration and customer-centric models. Beacon’s leadership appears to be betting that Patel’s execution-focused approach can help translate ambition into operational momentum.
Welcoming the appointment, Chairman Dr D K Joshi described Patel’s induction as a strategic move aligned with the group’s long-term vision, emphasising the role of leadership depth in navigating the next phase of growth.
For Beacon Group, the message is clear, in a sector where precision matters, leadership is the new differentiator—and this appointment is intended to set the tone for what comes next.
